ICAD INC (ICAD)
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.
Address
98 SPIT BROOK ROAD, SUITE 100
NASHUA, NH 03062
Founded
1984
Number of Employees
69
Website
http://www.icadmed.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
$111 | $87 | $114 | $184 | $186 | $92 | - | - | - | - | - | $129 |
| Average Price | $11.16 | $6.66 | $4.18 | $4.16 | $3.26 | $7.26 | - | - | - | - | - | $4.71 |
| # Shares Purchased | 9,904 | 13,058 | 27,299 | 44,082 | 56,946 | 12,723 | - | - | - | - | - | 27,335 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | -91.0% | -85.0% | -76.1% | -76.0% | -69.3% | -86.2% | - | - | - | - | - | -78.8% |
| S&P 500 Return to Date | 181.9% | 173.0% | 168.6% | 129.7% | 104.9% | 93.1% | - | - | - | - | - | 141.9% |
| Excess Total Return | -272.9% | -258.0% | -244.6% | -205.7% | -174.2% | -179.3% | - | - | - | - | - | -220.6% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | 3% | 4% | 7% | 6% | 7% | 2% | - | - | - | - | - | 5% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
People also followed
Never miss an email alert when insiders at ICAD make a trade.
Creating a free account takes less than one minute